Literature DB >> 21175366

A screening UHPLC-MS/MS method for the analysis of amyloid peptides in cerebrospinal fluid of preclinical species.

Lieve Dillen1, Willy Cools, Liesbeth Vereyken, Philip Timmerman.   

Abstract

BACKGROUND: Amyloid peptides are established biomarkers for Alzheimer's disease but their analysis presents major challenges.
RESULTS: In this article, we describe the use of ultra high-performance LC and API4000 triple quadrupole instrumentation for the quantification of amyloid peptides (Aβ(1-38) and Aβ(1-42)) in cerebrospinal fluid (CSF), using electrospray ionization with negative ion multiple reaction monitoring transitions. Sample preparation was simplified by the addition of acetonitrile and ammonium hydroxide. Although excellent sensitivity and precision was demonstrated, we observed differences in matrix suppression effects when using artificial CSF versus canine CSF for calibration curves and quality control samples.
CONCLUSION: A case study shows that the method can be used to determine the relative levels of two key peptides (Aβ(1-38) and Aβ(1-42)) compared with their predose values (a screening assay) in support of preclinical studies.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21175366     DOI: 10.4155/bio.10.163

Source DB:  PubMed          Journal:  Bioanalysis        ISSN: 1757-6180            Impact factor:   2.681


  4 in total

1.  Temperature-based on-column solute focusing in capillary liquid chromatography reduces peak broadening from pre-column dispersion and volume overload when used alone or with solvent-based focusing.

Authors:  Stephen R Groskreutz; Anthony R Horner; Stephen G Weber
Journal:  J Chromatogr A       Date:  2015-06-08       Impact factor: 4.759

2.  Pittsburgh compound B imaging and cerebrospinal fluid amyloid-β in a multicentre European memory clinic study.

Authors:  Antoine Leuzy; Konstantinos Chiotis; Steen G Hasselbalch; Juha O Rinne; Alexandre de Mendonça; Markus Otto; Alberto Lleó; Miguel Castelo-Branco; Isabel Santana; Jarkko Johansson; Sarah Anderl-Straub; Christine A F von Arnim; Ambros Beer; Rafael Blesa; Juan Fortea; Sanna-Kaisa Herukka; Erik Portelius; Josef Pannee; Henrik Zetterberg; Kaj Blennow; Agneta Nordberg
Journal:  Brain       Date:  2016-07-07       Impact factor: 13.501

3.  Deep Phosphoproteomic Measurements Pinpointing Drug Induced Protective Mechanisms in Neuronal Cells.

Authors:  Chengli Yu; Jing Gao; Yanting Zhou; Xiangling Chen; Ruoxuan Xiao; Jing Zheng; Yansheng Liu; Hu Zhou
Journal:  Front Physiol       Date:  2016-12-23       Impact factor: 4.566

4.  Investigating surrogate cerebrospinal fluid matrix compositions for use in quantitative LC-MS analysis of therapeutic antibodies in the cerebrospinal fluid.

Authors:  Jens Rose Fogh; Anne-Marie Jacobsen; Tam T T N Nguyen; Kasper D Rand; Line Rørbæk Olsen
Journal:  Anal Bioanal Chem       Date:  2020-02-01       Impact factor: 4.142

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.